Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.

Source:http://linkedlifedata.com/resource/pubmed/id/7903681

J. Exp. Med. 1994 Jan 1 179 1 341-6

Download in:

View as

Triples

General Info

PMID
7903681